The Technology

IlluminOss provides the world’s first minimally invasive, patient conforming polymer implant for fracture repair and stabilization. The IlluminOss System incorporates a Dacron®-like balloon catheter that is delivered through a small pathway into the intramedullary canal transiting the fracture site. Using a standard syringe, IlluminOss’ light activated, biocompatible monomer is infused into the balloon, causing it to expand, fill and conform to the patients intramedullary canal. Only upon the activation of IlluminOss’ visible light source will the monomer infused balloon begin to cure. The cured implant provides both longitudinal strength and rotational stability to allow for fracture repair and stabilization. Should ancillary fracture fixation systems be needed they can be placed anywhere along the implant.

How Does IlluminOss Work?

Slide 1

Step 1

A small diameter flexible balloon catheter is delivered through a small pathway that the surgeon makes in the bone and positioned across the break in the bone.
Slide 2

Step 2

A special "liquid glue" which hardens when blue light is shined on it, is delivered into the balloon catheter by a syringe. As the liquid fills the balloon, it expands and fills to the shape of the space inside the bone.
Slide 3

Step 3

The surgeon then turns on the blue light source which delivers the light into the balloon making the "liquid glue" harden and form itself to the space inside the bone.
Slide 4

Step 4

The hardened glue is like a cast on the inside of the bone, providing support and strength to the bone and allows the fracture to heal.

Key Advantages

  • A minimally invasive approach requiring a small incision minimizing potential soft tissue damage.
  • Implant conforms to the intramedullary canal providing strength and stability the fracture and compromised bone.
  • Small flexible ​delivery catheter​ allows the surgeon to define the optimal entry point of the implant.
  • Radiolucent for improved visibility of the cortex.
  • Radiopaque spiral markings provide a 3D profile of the implant.
  • Implants can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation.

Indications & Approvals

The IlluminOss Photodynamic Bone Stabilization System is indicated for use in skeletally mature patients in the treatment of traumatic, fragility, pathological, and impending pathological fractures of the humerus, radius, ulna, clavicle, pelvis, fibula, metacarpals, metatarsals, and phalanges. The IlluminOss Photodynamic Bone Stabilization System can also be used in conjunction with FDA-cleared fracture fixation systems to provide supplemental fixation in these anatomic sites. The IlluminOss System may be used in the femur and tibia to provide supplemental fixation to an anatomically appropriate FDA-cleared fracture fixation system.

For more detailed procedural information including Warnings, Cautions, Risks & Contraindications, please see the respective IlluminOss IFU’s Surgical Technique Guide, or Package insert